HomeInsights52 Week High Stocks

Natco Pharma Ltd 52 Week High

Natco Pharma Ltd 52 Week High

stocks purchased

₹ 3.9 Cr

Volume transacted

stocks purchased

27.8 K

stocks traded

Last Updated time: 05 Nov 14:08 PM

Image

Natco Pharma Ltd

NSE: NATCOPHARM

YEARHIGH

1638.35

Last updated on: Nov 04, 2024

Key Highlights

  • The 52 Week HIGH of Natco Pharma Ltd is ₹ 1638 as of 04 Nov 24.

Company Fundamentals for Natco Pharma Ltd

No data available

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Natco Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 20241409.5
01 Nov 20241426.9
31 Oct 20241403.05
30 Oct 20241382.2
29 Oct 20241341.1
28 Oct 20241322.4
25 Oct 20241292.3
24 Oct 20241339.1
23 Oct 20241318
22 Oct 20241328.15

Asset Value vs Market Value of Natco Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Natco Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Natco Pharma Ltd

No data available

* All values are in crore

Natco Pharma Ltd News Hub

News

Natco Pharma Ltd up for third straight session

Natco Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 138...

Read more

30 Oct 202413:05

News

Natco Pharma to announce Quarterly Result

Natco Pharma will hold a meeting of the Board of Directors of the Company on 12 November 2...

Read more

29 Oct 202414:02

News

Natco Pharma Ltd rises for third straight session

Natco Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 1460...

Read more

09 Oct 202413:05

News

Natco Pharma soars after Mylan settles Ozempic patent dispute

Natco Pharma announced that its partner, Mylan Pharmaceuticals Inc., reached a settlement ...

Read more

07 Oct 202415:28

News

Natco Pharma Ltd slips for fifth straight session

Natco Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 15...

Read more

19 Sep 202413:35

News

Natco Pharma invests USD 8 mn in bio-tech firm eGenesis

Natco Pharma announced that its wholly owned Canadian subsidiary, Natco Pharma (Canada) In...

Read more

04 Sep 202412:07

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week High of Natco Pharma Ltd

What is the significance of Natco Pharma Ltd reaching its 52-week high?

Natco Pharma Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Natco Pharma Ltd 52-week high?

Investors monitor Natco Pharma Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Natco Pharma Ltd a good buy when it hits its 52-week high?

Whether Natco Pharma Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Natco Pharma Ltd fundamentals.

What should I consider before investing in Natco Pharma Ltd at its 52-week high?

Before investing in Natco Pharma Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Natco Pharma Ltd stock price continue to rise after reaching its 52-week high?

Natco Pharma Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*